Bridgeway Capital Management, LLC Amgen Inc Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 1,900 shares of AMGN stock, worth $519,479. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,900

Previous 6,300 69.84%

Holding current value

$519,479

Previous $1.97 Million 68.9%

% of portfolio

0.01%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $1.36 Million - $1.48 Million	-4,400 Reduced 69.84%	1,900 $612,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $6.53 Million - $7.93 Million	-24,850 Reduced 79.78%	6,300 $1.97 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $3.95 Million - $4.77 Million	-14,700 Reduced 32.06%	31,150 $8.86 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $1.36 Million - $1.53 Million	-5,300 Reduced 10.36%	45,850 $13.2 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $3.16 Million - $3.92 Million	-14,445 Reduced 22.02%	51,150 $13.7 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.31 Million - $2.74 Million	-10,800 Reduced 14.14%	65,595 $14.6 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $2.47 Million - $3.01 Million	10,925 Added 16.69%	76,395 $18.5 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.15 Million - $2.73 Million	9,395 Added 16.75%	65,470 $17.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $3.19 Million - $3.59 Million	-14,200 Reduced 20.21%	56,075 $12.6 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.36 Million - $1.51 Million	-6,225 Reduced 8.14%	70,275 $17 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $15.2 Million - $17.4 Million	76,500 New	76,500 $17.2 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $21.7 Million - $25.9 Million	-100,375 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $12.9 Million - $14.3 Million	-54,875 Reduced 35.35%	100,375 $25.5 Million
Q2 2020 Aug 31, 2020	BUY	$197.81 - $242.74 $791,240 - $970,960	4,000 Added 2.64%	155,250 $36.6 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $17.3 Million - $21.3 Million	-87,700 Reduced 36.7%	151,250 $35.7 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $4.04 Million - $5.35 Million	-22,150 Reduced 8.48%	238,950 $48.4 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $13.3 Million - $17.1 Million	-70,250 Reduced 21.2%	261,100 $62.9 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $2.25 Million - $2.64 Million	13,500 Added 4.25%	331,350 $61.1 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $406,957 - $458,730	2,250 Added 0.71%	317,850 $60.4 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $553,040 - $645,575	3,100 Added 0.99%	315,600 $61.4 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $1.39 Million - $1.57 Million	7,500 Added 2.46%	312,500 $64.8 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $26.2 Million - $29.4 Million	157,500 Added 106.78%	305,000 $56.3 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $421,975 - $471,475	2,500 Added 1.72%	147,500 $25.7 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $24.3 Million - $27.7 Million	145,000	145,000 $27 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Amgen Inc Transaction History